3a), suggesting that DHHC9 is one of the PATs that regulate GLUT1 palmitoylation in GBM cells
On the whole, reasons for semaglutide differences are not fully understood and warrant further research, especially studies of real-world weight loss with semaglutide that include people without type 2 diabetes, like this one
L.SungJ.SongY.-M.et al (2016)
Yaghubi E, Daneshpazhooh M, DJalali M, Mohammadi H, Sepandar F, Fakhri Z, Ghaedi E, Keshavarz SA, Balighi K, Mahmoudi H, Zarei M, Javanbakht MH (2019) Effects of l -carnitine supplementation on cardiovascular and bone turnover markers in patients with pemphigus vulgaris under corticosteroids treatment: a randomized, doubleblind, controlled trial